Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies
Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if low intensity chemotherapy given
together with the new drug 90Y Zevalin, followed by a transplant of blood or marrow stem
cells from a donor can increase the length of remission in patients with leukemia and
lymphoma. The safety of this treatment will also be studied.